)
Sun Pharmaceutical on Tuesday reported 23 per cent increase in consolidated net profit to Rs 1,011.6 crore for the quarter ended March. Net profit in the year-ago period had stood at Rs 820 crore.
Total income from operations stood at Rs 3,087 crore, against Rs 2,336 crore in the year-ago period.
F9or 2012-13, consolidated net profit stood at Rs 3,008 crore, against Rs 2,657 crore in 2011-12.
Total income from operations was at Rs 11,300 crore, against Rs 8,020 crore in FY12.
Commenting on the performance, Managing Director Dilip Shanghvi said: "Our sales for FY13 have crossed the $2 billion mark. While it took us almost 27 years to record $1 billion in revenue, the next billion was added in just three years."
The board of directors at a have recommended issue of bonus shares to existing shareholders in the ratio of 1:1 subject to the receipt of approval of the equity shareholders, it said.
The board has also recommended payment of a dividend of Rs 5 per equity share of face value Rs 1 each, it added.
